How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block

December 2, 2020 updated by: Espen Lindholm, Sykehuset i Vestfold HF

How to Develop a Training Program for Nurses in Ultrasound Guided Femoral - a Methodology Study

In this study the intervention consists of a one-day-training program for nurses and three supervised ultrasound guided femoral nerve block (UGFNB) per registered nurse.

The training consists of an instruction movie, one-day on-site-simulation and practical examination. The nurses are watching an instruction video and review current local guidelines for UGFNB in advance. The one-day training is situated in a simulation center and consists of theoretical and practical training divided into; infection prevention, anatomy, use of ultrasound and prevention and treatment of complications. A ultrasound model (Gen II Femoral Vascular Access and Regional Anesthesia Ultrasound Training Model) and a living human model is used to examine the femoral nerve and the neighboring structures using ultrasound. At the end of the one-day course, the nurses attends a practical examination with the researchers and anesthesiologists observing, to assure that they could perform the UGFNB procedure correctly. To pass the exam and be able to move on to the supervised blocks in real patients, there has to be a consensus between the researchers and anesthesiologist that they had sufficient knowledge and practical skills. 1) Sterile procedure 2) Management of the ultrasound machine and oral description of the anatomic surroundings in the groin area 3) Preparation of the local anesthetics and performance of an UGFNB. They also have to do an oral presentation in how they would perform a cardiopulmonary resuscitation procedure and how to manage complications / toxic reactions. Approved exam required at least seven points. This study will explore if a one-day course as described above is adequate, sufficient and maintains the safety framework of performing UGFNB in nurses

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Acute pain is a common reason for patients admitted to Emergency Departments (ED) . Globally over 1 million hip fractures occur yearly , a trauma that is close related with acute distinct pain in the proximal part of the affected extremity. Experiencing severe pain is associated with increased length of stay, higher risk of delirium, movement restriction, difficulties with mobilization and reduced health related quality of life. There is considerable research regarding patients' satisfaction with their ED experiences. These studies indicate that patient dissatisfaction with the stay at ED has been an international challenge over several years . Disapproval such as; pain management , but also limited information on potential latency before further treatment and poor explanation about the causes and treatment of the condition is prominent.

Pain control can be difficult , and often requires advanced nursing and physician care due to co-morbidity . Inadequate analgesia appear to be risk factors for delirium in frail older adults, and research indicates that total avoiding opioids or using very low or high doses of opioids may increase the risk of delirium. Therefore, optimizing acute pain management is important. Ultrasound Guided Femoral Nerve block (UGFNB) performed in hip fracture patients is a valuable alternative to systemic analgesic, as it provides analgesia to the fractured area, thereby facilitating reduction in opioid administration. Traditionally, an UGFNB is performed by an anesthesiologist. Recently, several examples of task shifting from physicians to nurses are described with no significant difference in successful treatment results with equal patients satisfaction and safety as physician performed procedures. Task shifting approach is endorsed by the World Health Organization (WHO) in order to make more efficient use of the available human resource of health. A recent report from the European Union (EU) states that implementation of task shifting has been rarely evaluated and limited documented. Therefore, we need studies to examine the methodology in how we can train nurses in the ED to take more responsibility for assessing and treating patients.

In the study we aime to;

  1. describe a methodology for a training course for nurse led UGFNB.
  2. evaluate if the training process resulted in a safe and successful UGFNB.

Data which will be collected are

  1. ASA classification (ASA Physical Status Classification System )
  2. Length of stay
  3. Morbidity

    • Hospital acquired pneumonia
    • Acute myocardial infarction (AMI)
    • Acute renal failure
    • Respiratory failure
  4. Complication rate, number of;

    • intravasal injection - visually + circulatory and neurological symptoms
    • hematoma - defined as a new tumor > 2 cm in the groin / injection site measured by ultrasound
    • Neurologic systemic outcomes / symptoms / paresthesia that have occurred after admission and which persist until discharge.
    • Allergic reaction
  5. Number of total morphine equivalents, mg (iv/po) administered prehospital and during Emergency Department stay
  6. Patients physical characteristic (physical examination; gender, age, height, weight, , blood pressure, heart rate, SpO2 (oxygen saturation) and use of oxygen will be noted together with current disease

A short, but personal interview with the patients having received an UGFNB by a study nurse can describe both the service received and the patient's experience with it. The interviews will be performed after the patient has been relieved of pain. The PhD (Philosophiae Doctor)-candidate, not the study nurse having performed the nerve block, will conduct the interviews. The patients will be asked whether the nerve block relieved them of pain, how they experienced the procedure and the fact that it was performed by a nurse had any relevance. Also, the PhD-candidate will interview the patient at a later point during the hospital stay for a second time to compare the answers

The study nurses and the anesthesiologists that has supervised the nurses will be presented with a questionnaire after each UGFNB conducted. The PhD-candidate will hand out the questionnaire immediately after the FNB is conducted by a study nurse. The items in the questionnaire include feasibility and success of the procedure and are identical for nurses and anesthesiologists.

Finally, each study nurse will do three UGFNB with supervision by an anesthesiologist before we start inclusion in a later randomized controlled trial. Five study nurses will be included and fifteen patients.

The inclusion criteria for patients will be:

  • Patients arriving at the ED diagnosed with a hip fracture (radiological confirmed)
  • ASA- classification 1-4
  • Written and verbal informed consent by patient

Exclusion criteria for patients will be:

  • Patients with; dementia, without ability to give informed consent and other cognitively challenges needed to participate in this study (at the discretion of the study nurse)
  • Known allergies to local anesthetic (Ropivacaine) used in UGFNB
  • Use of anticoagulants or platelet inhibitors. Acetylsalicylic acid and dipyridamole is allowed. If a recent (last 2 hours) INR( international normalized ratio) is below <1.5 the patient can be included.
  • Pregnant
  • Age <18 years
  • Severe head injury which leads to significant loss of consciousness (GCS <12)
  • >10 mg or more morphine administrated pre-hospital
  • Skin lesions/infection at presumed block site
  • Patients admitted with other suspected or verified fractures, except small fractures in hands and foots.

Verbal and written informed consent The study nurses will inform the patients by oral and written information and inclusion and intervention of the patient will start after written consent.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tønsberg, Norway, 3103
        • Vestfold Hospital trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Registered nurses or registered nurses with continuing education in acute nursing or geriatrics
  • The nurses need to be aware that it will increase the workload in beginning of the project.
  • Registered nurse has to be senior staff experienced i.e. worked in the ED
  • Motivated to take on a new task in the ED
  • Certificated in advanced CPR
  • Familiar with routines in the ED and the relevant patient group
  • They must be willing to be a part of this project for approximately 12 months.
  • Working at least 75%.

Exclusion Criteria:

  • Refuse to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Emergency nurses
Emergency nurses who are trained in an one-day course
Emergency nurses who are trained for one-day in ultrasound-guided femoral nerve block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative Numerical Rating Scale (NRS) - during passive movement at 120 minutes after start of procedure, measured by 5 timepoints
Time Frame: 120 minutes
Cumulative Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED at 120 minutes after admission, measured by five time Points; At the end of procedure, 30 min.-, 60 min.-, 90 min.- and 120 min after start of procedure. NRS score: 0 is no pain and 10 is the worst pain.
120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hematoma
Time Frame: 24 hours
Hematoma - defined as a new tumor > 2 centimeter in the groin / injection site measured by ultrasound, Yes or no
24 hours
Numerical Rating Scale (NRS) - during passive movement at baseline
Time Frame: At baseline (timepoint 0)
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED at baseline (inclution of patient) NRS score: 0 is no pain and 10 is the worst pain.
At baseline (timepoint 0)
Numerical Rating Scale (NRS) - during passive movement after 30 minutes
Time Frame: After 30 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 30 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 30 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement after 60 minutes
Time Frame: After 60 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 60 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 60 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement after 90 minutes
Time Frame: After 90 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 90 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 90 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement after 120 minutes
Time Frame: After 120 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 120 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 120 minutes from baseline
Intravasal injection
Time Frame: 24 hours
Intravasal injection - visually + circulatory and neurological symptoms, yes or no
24 hours
Patient experience- description of pain
Time Frame: 24 hours
Patient experience of pain- During rest and motion measured by a 1-5 scale
24 hours
Patient satisfaction- waiting time to pain relief
Time Frame: 24 hours
Patiens experiences on waiting time to pain relief measured in a scale form 1-5
24 hours
Patient satisfaction- information
Time Frame: 24 hours
Patient experiences on information measured in a scale form 1-5
24 hours
Patient satisfaction- description of pain before the procedure
Time Frame: 24 hours
Patient experience on pre-procedure pain measured by 1-5 scale
24 hours
Patient satisfaction- description of pain after the procedure
Time Frame: 24 hours
Patient satisfaction- description of pain after the procedure measured by 1-5 scale
24 hours
Patient satisfaction- safety
Time Frame: 24 hours
Patient satisfaction- description of patient reported feeling of safety during nurse led procedure measured by a 1-5 scale
24 hours
Patient satisfaction-effect of procedure
Time Frame: 24 hours
Patient satisfaction regarding reduction of pain after the procedure measured by a 1-5 scale
24 hours
Patient satisfaction-hearing status
Time Frame: 24 hours
Patient satisfaction hearing status measured by a 1-4 scale
24 hours
Self reported-registered nurse- complexity
Time Frame: approximately 2 hours
Complexity of procedure measured by scale 1-5
approximately 2 hours
Self reported-registered nurse-success
Time Frame: approximately 2 hours
Success of procedure measured by 1-5 scale
approximately 2 hours
Self reported-registered nurse-Recognition of anatomic structures
Time Frame: approximately 2 hours
Recognition of anatomic structures at ultrasound, measured by a 1-4
approximately 2 hours
Self reported-registred nurse-spread of anesthesia
Time Frame: approximately 2 hours
Spread of anesthesia, measured by a 1-4 scale
approximately 2 hours
Self reported-registered nurse- patient benefit from procedure
Time Frame: approximately 2 hours
Patient benefit of procedure measured by a 1-5 scale
approximately 2 hours
Self reported-Anesthesiologist-complexity
Time Frame: approximately 2 hours
Complexity of procedure measured by scale 1-5
approximately 2 hours
Self reported-Anesthesiologist-success
Time Frame: approximately 2 hours
Success of procedure measured by a 1-5 scale
approximately 2 hours
Self reported-Anesthesiologist-Recognition of anatomic structures
Time Frame: approximately 2 hours
Recognition of anatomic structures at ultrasound measured by a 1-4 scale
approximately 2 hours
Self reported-Anesthesiologist-spread of anesthesia
Time Frame: approximately 2 hours
Spread of anesthesia, measured by a 1-4 scale
approximately 2 hours
Self reported-Anesthesiologist-Patient benefit of procedure
Time Frame: approxemitely 2 hours
Patient benefit of procedure measured by a 1-5 scale
approxemitely 2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elin Saga, nurse, The Hospital of Vestfold

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2019

Primary Completion (Actual)

January 30, 2020

Study Completion (Actual)

November 11, 2020

Study Registration Dates

First Submitted

November 12, 2020

First Submitted That Met QC Criteria

December 2, 2020

First Posted (Actual)

December 9, 2020

Study Record Updates

Last Update Posted (Actual)

December 9, 2020

Last Update Submitted That Met QC Criteria

December 2, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan for sharing IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Emergency nurses

3
Subscribe